Psychedelics and connectedness
This commentary paper (2017) proposes that connectedness is the key to its therapeutic potential.
Authors
- Robin Carhart-Harris
- David Erritzoe
- Mendel Kaelen
Published
Abstract
Psychedelic drugs are creating ripples in psychiatry as evidence accumulates of their therapeutic potential. An important question remains unresolved however: how are psychedelics effective? We propose that a sense of connectedness is key, provide some preliminary evidence to support this, and suggest a roadmap for testing it further.
Research Summary of 'Psychedelics and connectedness'
Introduction
Psychedelic drugs such as psilocybin, LSD and DMT (ayahuasca) are undergoing renewed scientific and cultural interest, and a recurring theme in contemporary discourse is that of "connectedness." Carhart-Harris and colleagues note that patients in their psilocybin for treatment-resistant depression (TRD) programme frequently described a renewed sense of connection following treatment. In qualitative follow-up interviews, all 17 patients who endorsed the treatment's effectiveness made reference to a sense of connectedness that the authors characterise as having three aspects: connection to the self, connection to others, and connection to the world at large. This paper sets out to propose connectedness as a potentially central psychological mediator of psychedelics' therapeutic effects. The authors present preliminary empirical observations from multiple sources (qualitative interviews from a TRD trial, a longitudinal web-based survey, prior psilocybin studies and neuroimaging work), argue for the need to operationalise and validate the construct, and outline a research roadmap to test whether acute phenomena such as ego-dissolution, mystical or unitive experiences and awe lead to enduring increases in connectedness that, in turn, drive clinical benefit.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Topics
- Authors
- APA Citation
Carhart-Harris, R. L., Erritzoe, D., Haijen, E., Kaelen, M., & Watts, R. (2018). Psychedelics and connectedness. Psychopharmacology, 235(2), 547-550. https://doi.org/10.1007/s00213-017-4701-y
References (10)
Papers cited by this study that are also in Blossom
Barrett, F. S., Johnson, M. W., Griffiths, R. R. · Journal of Psychopharmacology (2015)
Belser, A. B., Agin-Liebes, G. I., Swift, T. C. et al. · Journal of Humanistic Psychology (2017)
Carhart-Harris, R. L., Goodwin, G. M. · Neuropsychopharmacology (2017)
Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)
Carhart-Harris, R. L., Leech, R., Shanahan, M. et al. · Frontiers in Human Neuroscience (2014)
Forstmann, M., Sagioglou, C. · Journal of Psychopharmacology (2017)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Nour, M. R., Evans, J., Nutt, D. J. et al. · Frontiers in Human Neuroscience (2016)
Nour, M. R., Evans, J., Carhart-Harris, R. L. · Journal of Psychoactive Drugs (2017)
Tagliazucchi, E., Roseman, L., Kaelen, M. et al. · Current Biology (2016)
Cited By (86)
Papers in Blossom that reference this study
Schlomberg, J. T. T., Meling, D., Grylka, R. et al. · Scientific Reports (2026)
Kirlić, N., Atli, M., Mistry, S. et al. · Journal of Clinical Psychopharmacology (2025)
Zeifman, R. J., Spriggs, M. J., Kettner, H. et al. · Scientific Reports (2025)
Godfrey, K., Weiss, B., Zhang, X. et al. · Neuroscience Applied (2025)
Meling, D., Egger, K., Aicher, H. D. et al. · Journal of Psychopharmacology (2024)
Sloshower, J. A., Zeifman, R. J., Guss, J. et al. · Scientific Reports (2024)
Aday, J. S., Bloesch, E. K., Davis, A. K. et al. · Journal of Psychoactive Drugs (2024)
van der Kolk, B., Wang, J. B., Yehuda, R. et al. · PLOS ONE (2024)
Borkel, L. F., Rojas-Hernández, J., Henríquez-Hernández, L. A. et al. · Expert Review of Clinical Pharmacology (2023)
Van Elk, M., Fried, E. I. · Therapeutic Advances in Psychopharmacology (2023)
Show all 86 papersShow fewer
Heinzerling, K. G., Sergi, K., Linton, M. et al. · Frontiers in Psychiatry (2023)
Heifets, B. D., Olson, D. E. · Neuropsychopharmacology (2023)
Skosnik, P. D., Sloshower, J., Safi-Aghdam, H. et al. · Journal of Psychopharmacology (2023)
Chenhall, R., Sarris, J., Bouso, J. C. et al. · Psychoactives (2023)
Bloesch, E. K., Davis, A. K., Domoff, S. E. et al. · Psyarxiv (2023)
Newton, K., Moreton, S. G. · Ecopsychology (2023)
Luke, D., Gandy, S., Irvine, A. et al. · Psychoactives (2023)
Thal, S. B., Wieberneit, M., Sharbanee, J. M. et al. · Journal of Humanistic Psychology (2023)
Sjöstedt-Hughes, P. · Frontiers in Psychology (2023)
Michael, P., Luke, D., Robinson, O. · Frontiers in Psychology (2023)
Carhart-Harris, R. L., Chandaria, S., Erritzoe, D. E. et al. · Neuropharmacology (2023)
Jones, G. M., Lipson, J., Wang, E. · Scientific Reports (2023)
Moreton, S. G., Arena, A. F., Foy, Y. et al. · Death Studies (2023)
Perkins, D., Ruffell, S. G. D., day, K. et al. · Frontiers in Neuroscience (2023)
Thal, S. B., Wieberneit, M., Sharbanee, J. M. et al. · Journal of Psychopharmacology (2022)
Dourron, H. M., Strauss, C., Hendricks, P. S. · Pharmacological Reviews (2022)
Monroy, M., Keltner, D. · Perspectives on Psychological Science (2022)
Watts, R., Kettner, H., Gandy, S. et al. · Psychopharmacology (2022)
Moreton, S. G., Burden-Hill, A., Menzies, R. E. · Clinical Psychologist (2022)
van Elk, M., Yaden, D. B. · Neuroscience and Biobehavioral Reviews (2022)
Ching, T. H., Williams, M. T., Wang, J. B. et al. · Journal of Psychopharmacology (2022)
Amada, N., Shane, J. · Journal of Humanistic Psychology (2022)
Belser, A. B. · Frontiers in Psychology (2022)
Argento, E., Goldenberg, S., Deering, K. et al. · Drug and Alcohol Dependence (2022)
Glowacki, D. R., Wonnacott, M. D., Freire, R. et al. · Scientific Reports (2022)
Forstmann, M., Sagioglou, C. · European Psychologist (2022)
Whitney, S., Yaden, D. B., Lipson, J. et al. · Frontiers in Psychology (2022)
Ching, T. H., Williams, M. T., Reed, S. et al. · Journal of Humanistic Psychology (2022)
Argento, E., Socias, M. E., Hayashi, K. et al. · International Journal of Drug Policy (2022)
Schenberg, E. E., Gerber, K. · Transcultural Psychiatry (2022)
Dursun, S. M., Kelly, J. R., Gillan, C. M. et al. · Frontiers in Psychiatry (2021)
Nygart, V., Pommerencke, L. M., Carhart-Harris, R. L. et al. · Frontiers in Psychology (2021)
Johnstad, P. G. · Journal of Psychedelic Studies (2021)
Rodríguez Arce, J. M., Winkelman, M. J. · Frontiers in Psychology (2021)
Earp, B. D., Repantis, D., Langlitz, N. et al. · Frontiers in Psychiatry (2021)
Kočárová, C., Horacek, J., Carhart-Harris, R. L. · Frontiers in Psychiatry (2021)
Mans, K., Kettner, H., Erritzoe, D. et al. · Frontiers in Psychiatry (2021)
Teixeira, P. J., Johnson, M. W., Timmermann, C. et al. · Journal of Psychopharmacology (2021)
Lewis-Healey, E., Laukkonen, R., Van Elk, M. · Psyarxiv (2021)
Rush, B., Marcus, O., García, S. et al. · Frontiers in Pharmacology (2021)
Romeo, B., Hermand, M., Pétillion, A. et al. · Journal of Psychiatric Research (2021)
Kettner, H., Rosas, F. E., Timmermann, C. et al. · Frontiers in Pharmacology (2021)
Zeifman, R. J., Singhal, N., Breslow, L. et al. · ACS Pharmacology and Translational Science (2021)
Stauffer, C., Anderson, B. T., Ortigo, K. M. et al. · ACS Pharmacology and Translational Science (2020)
Nayak, S., Johnson, M. W. · Pharmacopsychiatry (2020)
Gandy, S., Forstmann, M., Carhart-Harris, R. L. et al. · Health Psychology Open (2020)
Brouwer, A., Carhart-Harris, R. L. · Journal of Psychopharmacology (2020)
Andersen, K. A. A., Carhart-Harris, R. L., Nutt, D. J. et al. · Acta Psychiatrica Scandinavica (2020)
Schmid, Y., Gasser, P., Oehen, P. et al. · Journal of Psychopharmacology (2020)
Anderson, B. T., Danforth, A. L., Daroff, R. et al. · EClinicalMedicine (2020)
Smigielski, L., Kometer, M., Scheidegger, M. et al. · Human Brain Mapping (2020)
Breeksema, J. J., Niemeijer, A. R., Krediet, E. et al. · CNS Drugs (2020)
Zeifman, R. J., Wagner, A. C., Watts, R. et al. · Frontiers in Psychiatry (2020)
Van Mulukom, V., Patterson, R. E., Van Elk, M. · Psychopharmacology (2020)
Smith, W. R., Sisti, D. · Journal of Medical Ethics (2020)
Castellanos, J. P., Woolley, C., Bruno, K. A. et al. · Regional Anesthesia and Pain Medicine (2020)
Glowacki, D. R., Wonnacott, M. D., Freire, R. et al. · Association for Computing Machinery (2020)
Aday, J. S., Mitzkovitz, C. M., Bloesch, E. K. et al. · Neuroscience and Biobehavioral Reviews (2020)
Wolff, M., Evens, R., Mertens, L. J. et al. · Frontiers in Psychiatry (2020)
Forstmann, M., Yudkin, D. A., Prosser, A. M. B. et al. · PNAS (2020)
Mertens, L. J., Wall, M. B., Roseman, L. et al. · Journal of Psychopharmacology (2020)
Kettner, H., Gandy, S., Haijen, E. C. H. M. et al. · International Journal of Environmental Research and Public Health (2019)
Carhart-Harris, R. L., Friston, K. J. · Pharmacological Reviews (2019)
Trope, A., Anderson, B. T., Hooker, A. R. et al. · Journal of Psychoactive Drugs (2019)
Erritzoe, D., Smith, J. M., Fisher, P. M. et al. · Journal of Psychopharmacology (2019)
Carhart-Harris, R. L. · Current Opinion in Psychiatry (2019)
Haijen, E. C. H. M., Kaelen, M., Roseman, L. et al. · Frontiers in Pharmacology (2018)
Hendricks, P. S. · International Review of Psychiatry (2018)
Schenberg, E. E. · Frontiers in Pharmacology (2018)
Jungaberle, H., Thal, S., Zeuch, A. et al. · Neuropharmacology (2018)
Erritzoe, D., Roseman, L., Nour, M. R. et al. · Acta Psychiatrica Scandinavica (2018)
Byock, I. · Journal of Palliative Medicine (2018)
Carhart-Harris, R. L. · Neuropharmacology (2018)
Swanson, L. R. · Frontiers in Pharmacology (2018)
Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)
Lyons, T., Carhart-Harris, R. L. · Journal of Psychopharmacology (2018)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.